Prognostic Value of a Rapid Sarcopenia Measure in Acutely Ill Older Adults

Overview

Journal Clin Nutr

Publisher Elsevier

Date 2019 Sep 19

PMID 31526610

Citations 13

Authors

Marlon J R Aliberti

Claudia Szlejf

Kenneth E Covinsky

Sei J Lee

Wilson Jacob-Filho

Claudia K Suemoto

Affiliations

Soon will be listed here.

Abstract

Background: Current recommendations to assess sarcopenia requiring specialized equipment hinder its use as a prognostic tool in busy acute settings.

Aims: To investigate the prognostic value of a rapid sarcopenia measure in acutely ill older outpatients for 1-year adverse outcomes.

Methods: Prospective study with 665 acutely ill older adults (mean age 78.7 ± 8.3 years; 63% women) in need of intensive management to avoid hospital admission. Sarcopenia was screened upon admission, defined as the presence of both low muscle strength and low muscle mass. Low muscle strength was determined by handgrip strength according to the cutoffs of the Foundation for the National Institutes of Health (<16 kg for women and <26 kg for men). Low muscle mass was assessed by calf circumference, a validated surrogate measure of skeletal muscle mass, using previously established thresholds (≤33 cm for women and ≤34 cm for men). Outcomes were time to hospitalization, new dependence in basic activities of daily living (ADL), worsening walking ability, and death. To investigate the association of sarcopenia and its components with outcomes we used hazard models, considering death as a competing risk, adjusted for sociodemographic factors, Charlson comorbidity index, cognitive impairment, depressive symptoms, and weight loss.

Results: On admission, 203 (31%) patients had sarcopenia. Comparing 1-year adverse outcomes between older adults with and without sarcopenia, respectively, cumulative incidences for hospitalization were 46% vs 32% (adjusted sub-hazard ratio [sHR] = 1.53; 95% CI = 1.16-2.04), for new ADL dependence, 47% vs 24% (adjusted sHR = 1.78; 95% CI = 1.31-2.42), for worsening walking ability, 28% vs 13% (adjusted sHR = 1.93; 95% CI = 1.28-2.90), and for death, 22% vs 10% (adjusted HR = 1.69; 95% CI = 1.05-2.73). Low muscle strength alone was associated with all outcomes, and low muscle mass was associated with all outcomes except mortality.

Conclusion: Sarcopenia was a strong predictor of 1-year adverse outcomes among acutely ill older outpatients. Combining handgrip strength with calf circumference may be a practical and efficient approach to screen for sarcopenia, and thereby identify high-risk older adults in busy clinical settings.

Citing Articles

Measuring calf circumference in frail hospitalized older adults and prediction of in-hospital complications and post-discharge mortality.

Canonico S, Ottaviani S, Tagliafico L, Casabella A, Signori A, Ponzano M Front Med (Lausanne). 2024; 11:1439353.

PMID: 39165376 PMC: 11333210. DOI: 10.3389/fmed.2024.1439353.

Combination of Parenteral Amino Acid Infusion and Intermittent Loading Exercise Ameliorates Progression of Postoperative Sarcopenia in Rat Model.

Wada A, Yamashita H, Togashi A, Ogawa S, Muroi A, Kido S Nutrients. 2024; 16(8).

PMID: 38674908 PMC: 11054099. DOI: 10.3390/nu16081218.

Impact of possible sarcopenia on functional prognosis in patients with acute stroke with premorbid disability.

Ogino T, Nozoe M, Inoue T, Ishida M, Yamamoto K Geriatr Gerontol Int. 2024; 24(4):359-363.

PMID: 38410028 PMC: 11503578. DOI: 10.1111/ggi.14840.

Impact of body composition on patient prognosis after SARS-Cov-2 infection.

Yamamoto T, Sugimoto K, Ichikawa S, Suzuki K, Wakabayashi H, Dohi K PLoS One. 2023; 18(7):e0289206.

PMID: 37506083 PMC: 10381082. DOI: 10.1371/journal.pone.0289206.

Handgrip strength as a diagnostic tool for frailty risk in elderly patients with moderate to severe asthma.

Figueiredo R, Holguin F, Pizzichini M, Pinheiro G, Arata V, Leal M J Bras Pneumol. 2023; 49(3):e20220465.

PMID: 37493789 PMC: 10578904. DOI: 10.36416/1806-3756/e20220465.

References

Chen L, Liu L, Woo J, Assantachai P, Auyeung T, Bahyah K . Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014; 15(2):95-101. DOI: 10.1016/j.jamda.2013.11.025. View

Fielding R, Vellas B, Evans W, Bhasin S, Morley J, Newman A . Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011; 12(4):249-56. PMC: 3377163. DOI: 10.1016/j.jamda.2011.01.003. View

Cruz-Jentoft A, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T . Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2018; 48(1):16-31. PMC: 6322506. DOI: 10.1093/ageing/afy169. View

Perez-Zepeda M, Gutierrez-Robledo L . Calf circumference predicts mobility disability: A secondary analysis of the Mexican health and ageing study. Eur Geriatr Med. 2016; 7(3):262-266. PMC: 5028111. DOI: 10.1016/j.eurger.2016.01.004. View

Cruz-Jentoft A, Baeyens J, Bauer J, Boirie Y, Cederholm T, Landi F . Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39(4):412-23. PMC: 2886201. DOI: 10.1093/ageing/afq034. View

Klee Oehlschlaeger M, Pastore C, Cavalli A, Gonzalez M . Nutritional status, muscle mass and strength of elderly in southern Brazil. Nutr Hosp. 2015; 31(1):363-70. DOI: 10.3305/nh.2015.31.1.7264. View

Kawakami R, Murakami H, Sanada K, Tanaka N, Sawada S, Tabata I . Calf circumference as a surrogate marker of muscle mass for diagnosing sarcopenia in Japanese men and women. Geriatr Gerontol Int. 2014; 15(8):969-76. DOI: 10.1111/ggi.12377. View

Yang M, Hu X, Wang H, Zhang L, Hao Q, Dong B . Sarcopenia predicts readmission and mortality in elderly patients in acute care wards: a prospective study. J Cachexia Sarcopenia Muscle. 2016; 8(2):251-258. PMC: 5377397. DOI: 10.1002/jcsm.12163. View

Maeda K, Koga T, Nasu T, Takaki M, Akagi J . Predictive Accuracy of Calf Circumference Measurements to Detect Decreased Skeletal Muscle Mass and European Society for Clinical Nutrition and Metabolism-Defined Malnutrition in Hospitalized Older Patients. Ann Nutr Metab. 2017; 71(1-2):10-15. DOI: 10.1159/000478707. View

10.

Beaudart C, Zaaria M, Pasleau F, Reginster J, Bruyere O . Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. PLoS One. 2017; 12(1):e0169548. PMC: 5240970. DOI: 10.1371/journal.pone.0169548. View

11.

Sousa A, Guerra R, Fonseca I, Pichel F, Amaral T . Sarcopenia among hospitalized patients - A cross-sectional study. Clin Nutr. 2015; 34(6):1239-44. DOI: 10.1016/j.clnu.2014.12.015. View

12.

Rubenstein L, Harker J, Salva A, Guigoz Y, Vellas B . Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci. 2001; 56(6):M366-72. DOI: 10.1093/gerona/56.6.m366. View

13.

DeLong E, Delong D, Clarke-Pearson D . Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44(3):837-45. View

14.

McLean R, Shardell M, Alley D, Cawthon P, Fragala M, Harris T . Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A Biol Sci Med Sci. 2014; 69(5):576-83. PMC: 3991140. DOI: 10.1093/gerona/glu012. View

15.

Galasko D, Bennett D, Sano M, Marson D, Kaye J, Edland S . ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Dis Assoc Disord. 2006; 20(4 Suppl 3):S152-69. DOI: 10.1097/01.wad.0000213873.25053.2b. View

16.

Bellelli G, Zambon A, Volpato S, Abete P, Bianchi L, Bo M . The association between delirium and sarcopenia in older adult patients admitted to acute geriatrics units: Results from the GLISTEN multicenter observational study. Clin Nutr. 2017; 37(5):1498-1504. DOI: 10.1016/j.clnu.2017.08.027. View

17.

Gariballa S, Alessa A . Sarcopenia: prevalence and prognostic significance in hospitalized patients. Clin Nutr. 2013; 32(5):772-6. DOI: 10.1016/j.clnu.2013.01.010. View

18.

Barbosa-Silva T, Bielemann R, Gonzalez M, Menezes A . Prevalence of sarcopenia among community-dwelling elderly of a medium-sized South American city: results of the COMO VAI? study. J Cachexia Sarcopenia Muscle. 2016; 7(2):136-43. PMC: 4864188. DOI: 10.1002/jcsm.12049. View

19.

Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

20.

Apolinario D, Lichtenthaler D, Magaldi R, Soares A, Busse A, Amaral J . Using temporal orientation, category fluency, and word recall for detecting cognitive impairment: the 10-point cognitive screener (10-CS). Int J Geriatr Psychiatry. 2015; 31(1):4-12. DOI: 10.1002/gps.4282. View